Records containing: Hepatitis C
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2020-12-07Evaluation of RIBAvirin Plasma COncentrations in Patients With Chronic Hepatitis C Infection Routinely Treated With Modern DAA Regimens
-
CLINICAL_TRIALS study record update · 2020-12-07A Drug-drug Interaction Study Between the Novel Anti-HCV Agent Daclatasvir and the Antiretroviral Agents Atazanavir/Ritonavir or Atazanavir/Cobicistat in Healthy Volunteers
-
CLINICAL_TRIALS study record update · 2020-12-07A Drug-drug Interaction Study Between the Novel Anti-hepatitis c Virus (HCV) Agent Daclatasvir and The Antidiabetic Agent Metformin in Healthy Volunteers
-
CLINICAL_TRIALS study record update · 2020-12-01Behavioral Science and Hepatitis C Screening Outreach
-
CLINICAL_TRIALS study record update · 2020-11-12A Prospective Cohort Study Comparing the Effectiveness of Zepatier for the Treatment of Hepatitis C in an Academic Center Population to People Who Inject Drugs (PWIDs) in a Safety Net Clinic Setting Engaged in Either a Medication Assisted Therapy (MAT) or Syringe Exchange Program
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2020-11-06Application of 18F-FDOPA PET in Research of the Association Between HCV Infection and Parkinson's Disease.
-
CLINICAL_TRIALS study record update · 2020-11-04New AbbVie Direct Acting Antiviral (DAA) Treatment of Chronic Hepatitis C Infection - Effects on the Macrophage Activation Marker Soluble CD163, Portal Hypertension, and Metabolic Liver Function
-
CLINICAL_TRIALS study record update · 2020-11-03Screening Hepatitis Positive Women for Congenital Anomalies During Pregnancy and Assessment of Liver Status of Women
-
CLINICAL_TRIALS study record update · 2020-10-22Effect of Direct-acting Antiviral Drugs on Erectile Function Among Hepatitis c Patients
-
CLINICAL_TRIALS study record update · 2020-10-19Bioequivalence Study of CRUshed ElbaSvir/GrAzoprevir compareD to the wholE Tablet (CRUSADE-2)/Hep-NED005
-
CLINICAL_TRIALS study record update · 2020-10-19Influence of the Acidic Beverage Cola on the Absorption of the HCV Agent Velpatasvir in Healthy Volunteers Being Treated With the Proton Pump Inhibitor Omeprazole.
-
CLINICAL_TRIALS study record update · 2020-10-19Association of Hepatitis C Virus Seropositivity With Breast Cancer Prognosis and Treatment Outcome
-
CLINICAL_TRIALS study record update · 2020-10-08Epidemiology of Chronic Hepatitis C and Modelling for Disease Burden Study
-
CLINICAL_TRIALS study record update · 2020-09-25Treatment as Prevention for Hepatitis C in Iceland. A Nationwide Campaign for Reducing Disease Burden Using Combination Antiviral Treatment
-
CLINICAL_TRIALS study record update · 2020-09-21A Follow-up Study to Assess Resistance and Durability of Response to AbbVie Direct-Acting Antiviral Agent (DAA) Therapy (ABT-493 and/or ABT-530) in Subjects Who Participated in Phase 2 or 3 Clinical Studies for the Treatment of Chronic Hepatitis C Virus (HCV) Infection
-
CLINICAL_TRIALS study record update · 2020-09-16The Effect of Aerobic Exercise on Liver Enzymes in Overweight Prediabetic Patients With Hepatitis c
-
CLINICAL_TRIALS study record update · 2020-09-14Open Label Trial to Study the Efficacy and Safety of MK-5172 and MK-8742 +/- Ribavirin (RBV) in the Treatment of Hepatitis C G1 and 4, in Patients Eligible for Liver Transplant (HCC) or Curative Therapy or Clinically Stable Disease Post Local Resection, Embolization or Ablative Therapy
-
CLINICAL_TRIALS study record update · 2020-08-24An Open-label Pilot Study to Determine the Safety and Efficacy of Fixed-dose Glecaprevir and Pibrentasvir Treatment in Hepatitis C Uninfected Recipients of Renal Transplants From Hepatitis C Infected Deceased Donors
-
CLINICAL_TRIALS study record update · 2020-08-14Integrating Health Psychology Into Hepatitis c Treatment: a Self-efficAcy Intervention to reDuce Injecting Risk behAviour and hePatitis c reinfecTion Rates
-
CLINICAL_TRIALS study record update · 2020-08-04A Respondent Driven Sampling Study to Identify the Hidden Population of Former Intravenous Drug Users With Hepatitis C Infection Who Are no Longer in Contact With Services. "Ask a Friend"
-
CLINICAL_TRIALS study record update · 2020-07-22CTN 0064: Assessing Long-term CTN 0049 Outcomes, HCV Prevalence and Progression Along the HCV Care Continuum Among HIV/HCV Co-infected Substance Users in the U.S.
-
CLINICAL_TRIALS study record update · 2020-07-21Examination of Changes of Parameters of Glucose Metabolism and Liver Fibrosis Stadium by Acoustic Radiation Force Impulse-Imaging and Transient Elastography in Patients With Chronic Hepatitis C Under Antiviral Treatment
-
CLINICAL_TRIALS study record update · 2020-07-21A Patient-Centered Intervention to Increase Screening of Hepatitis B and C Among Asian Americans
-
CLINICAL_TRIALS study record update · 2020-07-10Micro-elimination of Hepatitis C Virus Infection With Pan-genotypic DAA Regimen in Hepatitis C Highly Endemic and Contagious Community (ERASE-C)
-
CLINICAL_TRIALS study record update · 2020-07-07Insulin Resistance and Resistin In Non-Diabetic Patients With Chronic Hepatitis C Before and After Direct-Acting Antiviral Drugs.